Trastuzumab Completed Phase N/A Trials for Cognitive/Functional Effects / Long-Term Effects Secondary to Cancer Therapy in Adults / Chemotherapeutic Agent Toxicity / Neurologic toxicity / Psychosocial Effects of Cancer and Its Treatment / Tiredness / Cancer, Breast

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01152606A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
NCT01480674An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years
NCT01894711Real World Efficiency of Trastuzumab in Early Breast Cancer
NCT03390608Prognostic and Predictive Factors for Small Breast Tumors
NCT00755313Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
NCT02658461An Observational Time and Motion Study of Trastuzumab Subcutaneous (SC) and Intravenous (IV) Formulations in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (EBC)